ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 原著論文

Roles and limitations of FDG PET in pediatric non-Hodgkin lymphoma.

https://repo.qst.go.jp/records/46588
https://repo.qst.go.jp/records/46588
45018d2f-6666-4be1-9282-3889f0851189
Item type 学術雑誌論文 / Journal Article(1)
公開日 2013-08-28
タイトル
タイトル Roles and limitations of FDG PET in pediatric non-Hodgkin lymphoma.
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Nakatani, Koya

× Nakatani, Koya

WEKO 464366

Nakatani, Koya

Search repository
Nakamoto, Yuji

× Nakamoto, Yuji

WEKO 464367

Nakamoto, Yuji

Search repository
Saga, Tsuneo

× Saga, Tsuneo

WEKO 464368

Saga, Tsuneo

Search repository
Higashi, Tatsuya

× Higashi, Tatsuya

WEKO 464369

Higashi, Tatsuya

Search repository
Togashi, Kaori

× Togashi, Kaori

WEKO 464370

Togashi, Kaori

Search repository
et.al

× et.al

WEKO 464371

et.al

Search repository
佐賀 恒夫

× 佐賀 恒夫

WEKO 464372

en 佐賀 恒夫

Search repository
抄録
内容記述タイプ Abstract
内容記述 The usefulness of 18F fluorodeoxyglucose (FDG) positron emission tomography (PET) in pediatric Hodgkin lymphoma (p-HL) has been well demonstrated; however, pediatric non-Hodgkin lymphoma (p-NHL) has distinct characteristics from p-HL and adult NHL. We assessed roles of FDG PET in p-NHL.
Nineteen patients with p-NHL underwent 80 scans. Scans for staging (group A, n=6) and response assessment (group B, n=42) were compared with conventional imaging modalities (CIMs). Scans within group B for end-chemotherapy assessment (subgroup B+, n=11) and for post-therapeutic surveillance (group C, n=32) were analyzed for diagnostic performance.
In group A, PET and CIM demonstrated comparable results. In group B, PET diagnoses were concordant with CIM in 21 and discordant in 11 studies. Of the discordant cases, PET suggested remnant lesions in 5 cases, whereas CIM suggested lesions in 6 cases. PET modified therapeutic strategy in 4 cases by detecting new extranodal lesions. In subgroup B+, sensitivity, specificity, and accuracy for predicting relapse were 50%, 71%, and 64%, respectively. In group C, sensitivity, specificity, and accuracy were 100%, 87%, and 88%, respectively, but positive predictive value was 33%.
The role of FDG PET in p-NHL may be limited, unlike with p-HL or adult NHL. Nevertheless, FDG PET may serve complementarily in detecting unexpected lesions that can emerge in p-NHL.
書誌情報 Clinical Nuclear Medicine

巻 37, 号 7, p. 656-662, 発行日 2012-07
ISSN
収録物識別子タイプ ISSN
収録物識別子 0363-9762
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 23:49:58.455951
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3